Table 1.
Patient Characteristics
| nRVF (n = 11) | iRVF (n = 10) | |
|---|---|---|
| Age, y | 53.7 ± 14.7 | 49.5 ± 14.3 |
| Female/male | 3 (27.3)/8 (72.7) | 4 (40)/6 (60) |
| BMI, kg/m2 | 26.0 ± 3.7 | 25.9 ± 3.8 |
| Etiology of DCM | ||
| Genetic | 1 (9) | 2 (20) |
| Myocarditis | 2 (18.2) | 3 (30) |
| Other | 8 (72.8) | 5 (50) |
| Smoking | 5 (45.5) | 1 (10) |
| Hypertension | 6 (54.6) | 5 (50) |
| Peripheral artery disease | 0 | 0 |
| Stroke | 0 | 0 |
| Diabetes mellitus | 2 (18.2) | 4 (40) |
| Renal insufficiency (GFR categories ≥G3b) | 2 (18.2) | 4 (40) |
| Chronic obstructive pulmonary disease | 0 | 0 |
| Previous myocardial infarction | 0 | 0 |
| Prior percutaneous coronary intervention | 0 | 0 |
| Prior cardiac surgery | 1 (9.1) | 0 |
| Atrial fibrillation | 4 (36.4) | 4 (40) |
| Permanent pacemaker | 2 (18.2) | 0 |
| CRT implanted | 6 (54.6) | 5 (50) |
| Medication | ||
| Diuretics | 10 (90.9) | 10 (100) |
| Beta-blockade | 8 (72.7) | 9 (90) |
| ACE-I, ARB | 7 (63.6) | 9 (90) |
| Valsartan/sacubitril | 4 (36.4) | 2 (20) |
| Ivabradine | 1 (9.1) | 1 (10) |
| Marcumar | 4 (36.4) | 6 (60) |
| NOAC | 1 (9.1) | 1 (10) |
| Glucocorticoid | 2 (18.2) | 1 (10) |
| Tacrolimus | 1 (9.1) | 1 (10) |
| Statin | 3 (27.3) | 1 (10) |
Values are mean ± SD or n (%). Statistical significance was calculated for numerical data using 2-tailed unpaired Student’s t-test and for categorical data using Fisher exact test. No statistical differences were observed.
ACE-I = angiotensin-converting enzyme inhibitor; ARB = angiotensin receptor blocker; BMI = body mass index; GFR = glomerular filtration rate; iRVF = severely impaired right ventricular function; NOAC = novel oral anticoagulant; nRVF = normal right ventricular function.